Pak-Saudi Study: COVID Vaccines Safe, Boost Immunity

A collaborative research initiative between Khyber Pakhtunkhwa's KMU and Jeddah's King Abdulaziz University has concluded that COVID-19 vaccines are safe and do not cause adverse effects. The study, published in the Biomedicines Journal UK, found that vaccination effectively enhanced the immunity of recipients, providing protection against the virus that caused significant mortality in Pakistan.

Researchers highlighted that the study aimed to present vaccination realistically, acknowledging its ability to generate strong immune responses while also noting measurable biological changes that require ongoing monitoring. This evidence is crucial for policymakers reassessing booster strategies and risk communication. The research has drawn international attention, underscoring the growing visibility of Pakistani scientific contributions on a global scale.

Further analysis from the research group indicated high SARS-CoV-2 antibody prevalence in unvaccinated older adults, suggesting that widespread prior exposure also shaped immunity patterns in Pakistan. This emphasizes the importance of tailoring vaccination policies and pandemic planning to local evidence and realities. While generally safe, some long-term studies noted instances of heart diseases and blood clotting, particularly in younger individuals, though immediate vaccination effects were the focus of the Pak-Saudi study.